SCHEMBL4760458

SCHEMBL4760458

CN(CCCN)CCCc1ccc(Cl)c(Cl)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 18/20 0.59
TP53 P04637 3/20 0.59
CYP1A2 P05177 3/20 0.59
MEN1 O00255 1/20 0.59
ALDH1A1 P00352 1/20 0.59
MAPT P10636 1/20 0.59
CYP2C19 P33261 1/20 0.59
KMT2A Q03164 1/20 0.59
PNMT P11086 1/20 0.58
TAAR1 Q96RJ0 1/20 0.58
KCNH2 Q12809 1/20 0.51
CYP2D6 P10635 2/20 0.50
TSHR P16473 2/20 0.50
GRIN2D O15399 1/20 0.49
GRIN3B O60391 1/20 0.49
CYP3A4 P08684 1/20 0.49
GRIN1 Q05586 1/20 0.49
GRIN2A Q12879 1/20 0.49
GRIN2B Q13224 1/20 0.49
GRIN2C Q14957 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9160104 0.89 SIGMAR1 (0.67) SIGMAR1TP53CYP1A2MEN1ALDH1A1
SCHEMBL2538061 0.85 SIGMAR1 (0.58) SIGMAR1TP53CYP1A2MEN1ALDH1A1
SCHEMBL4037320 0.82 PNMT (0.76) SIGMAR1TP53CYP1A2MEN1ALDH1A1
SCHEMBL31497388 0.81 PNMT (0.73) SIGMAR1TP53CYP1A2MEN1ALDH1A1
SCHEMBL4714764 0.81 PNMT (0.73) SIGMAR1TP53CYP1A2MEN1ALDH1A1
Hydrochloric Acid SCHEMBL14829816 0.81 PNMT (0.73) SIGMAR1TP53CYP1A2MEN1ALDH1A1
SCHEMBL4719127 0.80 SIGMAR1 (0.55) SIGMAR1TP53CYP1A2MEN1ALDH1A1
SCHEMBL11332031 0.79 PNMT (0.70) SIGMAR1CYP1A2MEN1CYP2C19KMT2A
SCHEMBL11331998 0.79 PNMT (0.70) SIGMAR1CYP1A2MEN1CYP2C19KMT2A
SCHEMBL11324805 0.79 PNMT (0.70) SIGMAR1CYP1A2MEN1CYP2C19KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080293745-A1 New amino-alkyl-amide derivatives as CCR3 receptor ligands SANOFI-AVENTIS (FR) 2008-11-27 US disclosed
EP-1931627-A1 AMINO-ALKYL-AMIDE DERIVATIVES AS CCR3 RECEPTOR LIGANDS Sanofi-Aventis (FR) 2008-06-18 EP disclosed
WO-2007034251-A1 AMINO-ALKYL-AMIDE DERIVATIVES AS CCR3 RECEPTOR LIGANDS SANOFI-AVENTIS (FR) 2007-03-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293745-A1 New amino-alkyl-amide derivatives as CCR3 receptor ligands CCR3, CCR1, CCR4 SIGMAR1 636/4885TP53 3528/4885CYP1A2 2460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.